Blood Pressure Study
In a controlled lab study completed
in April of 1998, The American equivalent of Oxyrich, the AO2C
product was tested to determine if oral consumption of the AO2C
would have any effect on the systolic and diastolic blood pressure
as well as capillary dilation of the test subjects.
It was determined that: " Of the 6
test subjects given the AO2C, all exhibited some degree of capillary
dilation… (and) all exhibited a reduction in the systolic and
diastolic blood pressure ranging from 2 to 8 points systolic and
from 6 to 14 points diastolic."
The conclusion of the study: " The
combination of component ingredients in AO2C has a positive affect,
in varying degrees, on capillary dilation… (and) a significant
affect on the reduction of systolic and diastolic blood pressures.
It is the researchers opinion that AO2C results in greater metabolic
efficiency which may correlate to significant energy reductions thus
prolonging and enhancing the quality of an individual’s life.
Acknowledgement: This Study was
sponsored by Bio2 International
Oxyrich Technical Data